Charles Schneider MD Professor of Medicine, FACP
Gastrointestinal Cancer
Abramson Cancer Center University of Pennsylvania
Join to View Full Profile
Abramson Cancer Center, University of PennsylvaniaPerelman South 10-104, 3400 Civic Center BoulevardPhiladelphia, PA 19104
Phone+1 215-615-5810
Fax+1 215-662-2432
Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1993 - 1995- University of Pennsylvania Health SystemResidency, Internal Medicine, 1990 - 1993
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990
Certifications & Licensure
PA State Medical License 1992 - 2026
DE State Medical License 1995 - 2019
NJ State Medical License 1995 - 2005
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1999
Publications & Presentations
PubMed
- A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors.Cathy Eng, Nehal J Lakhani, Philip A Philip, Charles Schneider, Benny Johnson
Targeted Oncology. 2025-03-26 - 28 citationsNCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.Al B Benson, Alan P Venook, Mohamed Adam, George Chang, Yi-Jen Chen
Journal of the National Comprehensive Cancer Network. 2024-08-01 - 4 citationsCirculating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.Jacob E Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M Pfeiffer
Nature Communications. 2024-07-09
Press Mentions
More Aggressive Treatment Doesn’t Impact Quality of Life for Metastatic Colorectal Cancer Patients, According to New Study in JNCCNOctober 13th, 2023- Study Shows Tumor Debulking Has No Impact on Quality of Life in Metastatic Colorectal CancerOctober 26th, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
